Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study-Reference-Cited by-同舟云学术

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Published:2021-03 Issue:3 Volume:74 Page:567-577
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Marjot Thomas^ORCID,Moon Andrew M.,Cook Jonathan A.,Abd-Elsalam Sherief,Aloman Costica,Armstrong Matthew J.,Pose Elisa,Brenner Erica J.,Cargill Tamsin,Catana Maria-Andreea,Dhanasekaran Renumathy,Eshraghian Ahad,García-Juárez Ignacio,Gill Upkar S.,Jones Patricia D.,Kennedy James,Marshall Aileen,Matthews Charmaine,Mells George,Mercer Carolyn,Perumalswami Ponni V.,Avitabile Emma,Qi Xialong,Su Feng,Ufere Nneka N.^ORCID,Wong Yu Jun,Zheng Ming-Hua,Barnes Eleanor,Barritt Alfred S.,Webb Gwilym J.

Funder

National Institutes of Health

NIHR Oxford Biomedical Research Centre

North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill

European Association for the Study of the Liver

Wellcome Trust

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis;Yang;Int J Infect Dis,2020